There have been 50 recent insider transactions recorded for Akero Therapeutics, Inc. (AKRO), including 10 buys and 40 sells. Total insider buying was valued at $8.79M and total insider selling at $8.67M.
Notable insiders with recent activity include Lamy Patrick, Gangloff Scott A., Cheng Andrew. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — AKRO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-06-20 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
875 |
$54.59 |
$47.77K |
31,698 |
| 2025-06-18 |
Gangloff Scott A. |
Chief Technology Officer |
Informative Sell |
848 |
$54.84 |
$46.5K |
23,452 |
| 2025-06-18 |
Cheng Andrew |
President and CEO |
Informative Sell |
6,620 |
$54.84 |
$363.04K |
549,867 |
| 2025-06-18 |
White William Richard |
Chief Financial Officer |
Informative Sell |
1,634 |
$54.84 |
$89.61K |
57,521 |
| 2025-06-18 |
Yale Catriona |
Chief Development Officer |
Informative Sell |
1,633 |
$54.84 |
$89.55K |
90,598 |
| 2025-06-18 |
Rolph Timothy |
Chief Scientific Officer |
Informative Sell |
1,129 |
$54.84 |
$61.91K |
166,234 |
| 2025-06-18 |
Young Jonathan |
Chief Operating Officer |
Informative Sell |
1,453 |
$54.84 |
$79.68K |
196,594 |
| 2025-06-16 |
Yale Catriona |
Chief Development Officer |
Option Exercise (Sell) |
10,000 |
$21.10 |
$211K |
- |
| 2025-06-16 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
500 |
$55.09 |
$27.55K |
32,573 |
| 2025-06-10 |
Cheng Andrew |
President and CEO |
Informative Sell |
7,837 |
$53.99 |
$423.15K |
556,487 |
| 2025-06-10 |
White William Richard |
Chief Financial Officer |
Informative Sell |
2,804 |
$54.00 |
$151.4K |
59,155 |
| 2025-06-10 |
Yale Catriona |
Chief Development Officer |
Informative Sell |
2,803 |
$54.00 |
$151.35K |
92,231 |
| 2025-06-10 |
Rolph Timothy |
Chief Scientific Officer |
Informative Sell |
2,358 |
$54.00 |
$127.32K |
167,363 |
| 2025-06-10 |
Young Jonathan |
Chief Operating Officer |
Informative Sell |
2,493 |
$53.99 |
$134.6K |
198,047 |
| 2025-06-10 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
919 |
$54.00 |
$49.63K |
32,573 |
| 2025-06-06 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
389 |
$21.10 |
$8.21K |
- |
| 2025-06-05 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
12,500 |
$21.10 |
$263.75K |
389 |
| 2025-06-03 |
Harrison Seth Loring |
Director |
RSU Award |
9,398 |
- |
- |
145,699 |
| 2025-06-03 |
Iwicki Mark T |
Director |
RSU Award |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Henderson Jane |
Director |
RSU Award |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Graham G. Walmsley |
Director |
RSU Award |
9,398 |
- |
- |
11,566 |
| 2025-06-03 |
Heyman Tomas J. |
Director |
RSU Award |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Xu Yuan |
Director |
RSU Award |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Judy Chou |
Director |
RSU Award |
9,398 |
- |
- |
9,398 |
| 2025-06-02 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
100 |
$51.04 |
$5.1K |
33,492 |
| 2025-05-22 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
4,000 |
$50.00 |
$200K |
33,492 |
| 2025-05-15 |
Yale Catriona |
Chief Development Officer |
Option Exercise (Sell) |
10,000 |
$21.10 |
$211K |
10,000 |
| 2025-05-12 |
Cheng Andrew |
President and CEO |
Informative Sell |
22,800 |
$41.63 |
$949.26K |
594,324 |
| 2025-05-07 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
3,299 |
$42.76 |
$141.06K |
33,492 |
| 2025-05-06 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
12,500 |
$21.10 |
$263.75K |
12,889 |
| 2025-04-24 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
3,684 |
$21.10 |
$77.73K |
25,389 |
| 2025-04-15 |
Yale Catriona |
Chief Development Officer |
Option Exercise (Sell) |
9,073 |
$21.10 |
$191.44K |
20,000 |
| 2025-04-10 |
Cheng Andrew |
President and CEO |
Informative Sell |
30,000 |
$35.23 |
$1.06M |
624,324 |
| 2025-04-07 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
6,250 |
$21.10 |
$131.88K |
28,718 |
| 2025-03-27 |
Graham G. Walmsley |
Director |
Informative Buy |
50,000 |
$43.55 |
$2.18M |
1,200,000 |
| 2025-03-26 |
Graham G. Walmsley |
Director |
Informative Buy |
58,691 |
$43.01 |
$2.52M |
1,150,000 |
| 2025-03-25 |
Graham G. Walmsley |
Director |
Informative Buy |
91,309 |
$44.75 |
$4.09M |
1,091,309 |
| 2025-03-17 |
Yale Catriona |
Chief Development Officer |
Option Exercise (Sell) |
10,000 |
$21.10 |
$211K |
- |
| 2025-03-12 |
Cheng Andrew |
President and CEO |
Informative Sell |
1,738 |
$44.88 |
$78K |
654,324 |
| 2025-03-12 |
White William Richard |
Chief Financial Officer |
Informative Sell |
676 |
$44.88 |
$30.34K |
61,959 |
| 2025-03-12 |
Yale Catriona |
Chief Development Officer |
Informative Sell |
614 |
$44.88 |
$27.56K |
95,034 |
| 2025-03-12 |
Rolph Timothy |
Chief Scientific Officer |
Informative Sell |
516 |
$44.88 |
$23.16K |
169,721 |
| 2025-03-12 |
Young Jonathan |
Chief Operating Officer |
Informative Sell |
607 |
$44.88 |
$27.24K |
200,540 |
| 2025-03-10 |
Cheng Andrew |
President and CEO |
Informative Sell |
1,216 |
$42.31 |
$51.45K |
656,062 |
| 2025-03-05 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
12,500 |
$21.10 |
$263.75K |
34,968 |
| 2025-03-04 |
Young Jonathan |
Chief Operating Officer |
Informative Sell |
38,553 |
$45.07 |
$1.74M |
201,147 |
| 2025-03-03 |
Lamy Patrick |
Senior VP, Commercial Strategy |
Informative Sell |
1,000 |
$48.09 |
$48.09K |
33,492 |
| 2025-02-18 |
Yale Catriona |
Chief Development Officer |
Option Exercise (Sell) |
10,000 |
$21.10 |
$211K |
10,000 |
| 2025-02-10 |
Cheng Andrew |
President and CEO |
Informative Sell |
200 |
$55.81 |
$11.16K |
686,062 |
| 2025-02-05 |
Rolph Timothy |
Chief Scientific Officer |
Option Exercise (Sell) |
18,750 |
$21.10 |
$395.63K |
47,468 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
